Bookmark and Share
NCGC00025040-01 (CID 6604828) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(2)
 
 
Inactive(89)
 
 
Inconclusive(5)
 
 
Unspecified(4)
 
 
Top Targets:
p450(9)
 
 
 
 
HSD10-like SD..(4)
 
 
PLDc mTdp1 2(3)
 
 
Tubulin-bindi..(3)
 
 
 
IMPase(2)
 
 
BioAssay Types:
Confirmatory(89)
 
 
 
 
Literature(4)
 
 
 
Screening(1)
 
 
BioActivity Types:
Potency(69)
 
 
 
IC50(4)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 90    Data Row: 100   Total Pages: 5   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103318174]
IC50 23.73Affinity value against N-methyl-D-aspartate (NMDA) receptor using [3H]-CGS- 19755 in glutamate radioligand binding assay. [AID144463, Type: Literature]
View
2
[SID11113958]
p450-cyp1a2 [AID410, Type: confirmatory]cytochrome P450 1A2 [Homo sapiens] [gi:73915100]
View
3
[SID103318174]
IC50 100Affinity against Ionotropic glutamate receptor AMPA using [3H]AMPA in selective radioligand binding assay [AID92205, Type: Literature]
View
4
[SID103318174]
IC50 100Affinity value against Ionotropic glutamate receptor kainate using [3H]-kainic acid in selective radioligand binding assay. [AID93555, Type: Literature]
View
5
[SID103318174]
IC50 100In vitro ability to displace [3H]glutamate binding to metabotropic glutamate receptors in rat forebrain membranes [AID108348, Type: Literature]
View
6
[SID11113958]
Cytochrome panel assay with activity outcomes [AID1851, Type: other]
View
7
[SID11113958]
Potency Quantitative High-Throughput Screen for Regulators of Epigenetic Control [AID1865, Type: confirmatory]
View
8
[SID11113958]
Potency qHTS Assay for Compounds that Induce Erasure of Genomic Imprints [AID1948, Type: confirmatory]
View
9
[SID11113958]
Potency qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region [AID923, Type: confirmatory]
View
10
[SID11113958]
Potency Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1463, Type: confirmatory]
View
11
[SID11113958]
Potency qHTS Assay for Lipid Storage Modulators [AID1519, Type: confirmatory]
View
12
[SID11113958]
Potency qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory]Microtubule-associated protein tau [Homo sapiens] [gi:92096784]
View
13
[SID11113958]
Potency qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory]Microtubule-associated protein tau [Homo sapiens] [gi:92096784]
View
14
[SID11113958]
Potency qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature [AID902, Type: confirmatory]cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068]
View
15
[SID11113958]
Potency qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature [AID924, Type: confirmatory]cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068]
View
16
[SID11113958]
Potency VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory]nuclear receptor ROR-gamma isoform 1 [Mus musculus] [gi:188536040]
View
17
[SID11113958]
Potency qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory]nuclear receptor ROR-gamma isoform 1 [Mus musculus] [gi:188536040]
View
18
[SID11113958]
Potency qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia [AID1477, Type: confirmatory]
View
19
[SID11113958]
Potency qHTS for Inhibitors of binding or entry into cells for Lassa Virus [AID720533, Type: confirmatory]
View
20
[SID11113958]
Cytochrome panel assay with activity outcomes [AID1851_2, Type: other]cytochrome P450 2D6 isoform 2 [Homo sapiens] [gi:68509921]
View